| Primary |
| Product Used For Unknown Indication |
25.4% |
| Blood Testosterone Decreased |
22.5% |
| Drug Use For Unknown Indication |
8.5% |
| Hypogonadism |
8.5% |
| Hormone Replacement Therapy |
5.6% |
| Drug Abuse |
4.2% |
| Erectile Dysfunction |
2.8% |
| Growth Hormone Deficiency |
2.8% |
| Hypogonadism Male |
2.8% |
| Klinefelter's Syndrome |
2.8% |
| Off Label Use |
2.8% |
| Dupuytren's Contracture |
1.4% |
| Eosinophilic Colitis |
1.4% |
| Myasthenia Gravis |
1.4% |
| Osteopenia |
1.4% |
| Pituitary Cyst |
1.4% |
| Product Contamination Microbial |
1.4% |
| Skin Irritation |
1.4% |
| Testicular Failure |
1.4% |
|
| Product Quality Issue |
16.1% |
| Injection Site Abscess |
12.9% |
| Drug Ineffective |
6.5% |
| No Adverse Event |
6.5% |
| Prostate Cancer |
6.5% |
| Vomiting |
6.5% |
| Acute Myocardial Infarction |
3.2% |
| Anger |
3.2% |
| Benign Intracranial Hypertension |
3.2% |
| Blood Lactate Dehydrogenase Increased |
3.2% |
| Breast Cancer |
3.2% |
| Cellulitis |
3.2% |
| Dermatitis Allergic |
3.2% |
| Disinhibition |
3.2% |
| Drug Dispensing Error |
3.2% |
| Erectile Dysfunction |
3.2% |
| Erythema |
3.2% |
| Haemangioma |
3.2% |
| Haemoptysis |
3.2% |
| Hyperkalaemia |
3.2% |
|
| Secondary |
| Antiretroviral Therapy |
26.3% |
| Blood Testosterone Decreased |
14.5% |
| Hormone Replacement Therapy |
10.5% |
| Hypogonadism |
7.9% |
| Drug Use For Unknown Indication |
6.6% |
| Hepatitis C Virus Test Positive |
3.9% |
| Product Used For Unknown Indication |
3.9% |
| Anxiety |
2.6% |
| Benign Prostatic Hyperplasia |
2.6% |
| Cachexia |
2.6% |
| Depression |
2.6% |
| Hypertension |
2.6% |
| Pain |
2.6% |
| Protein Anabolism Increased |
2.6% |
| Affective Disorder |
1.3% |
| Cough |
1.3% |
| Diabetes Mellitus |
1.3% |
| Diarrhoea |
1.3% |
| Hypogonadism Male |
1.3% |
| Muscle Spasms |
1.3% |
|
| Acne |
9.1% |
| Muscle Hypertrophy |
9.1% |
| Sex Hormone Binding Globulin Decreased |
9.1% |
| Weight Decreased |
9.1% |
| Breast Cancer |
4.5% |
| Chest Pain |
4.5% |
| Drug Abuse |
4.5% |
| Drug Ineffective |
4.5% |
| Injection Site Swelling |
4.5% |
| Mastectomy |
4.5% |
| Palpitations |
4.5% |
| Priapism |
4.5% |
| Product Quality Issue |
4.5% |
| Pyrexia |
4.5% |
| Scrotal Pain |
4.5% |
| Secondary Hypogonadism |
4.5% |
| Syncope |
4.5% |
| Urinary Retention |
4.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
33.0% |
| Drug Use For Unknown Indication |
9.3% |
| Hypertension |
5.6% |
| Crohn's Disease |
5.4% |
| Asthma |
4.1% |
| Hiv Infection |
4.1% |
| Vitamin Supplementation |
4.1% |
| Multiple Myeloma |
3.9% |
| Depression |
3.5% |
| Pain |
3.5% |
| Insomnia |
3.4% |
| Gastrooesophageal Reflux Disease |
3.0% |
| Prophylaxis |
3.0% |
| Chronic Obstructive Pulmonary Disease |
2.6% |
| Blood Cholesterol Increased |
2.0% |
| Constipation |
2.0% |
| Anxiety |
1.9% |
| Cellulitis |
1.9% |
| Hypopituitarism |
1.9% |
| Supplementation Therapy |
1.9% |
|
| Pain In Extremity |
11.8% |
| Osteonecrosis |
9.8% |
| Weight Increased |
9.8% |
| Pain |
5.9% |
| Cellulitis |
3.9% |
| Cellulitis Staphylococcal |
3.9% |
| Death |
3.9% |
| Gastrooesophageal Reflux Disease |
3.9% |
| Hepatic Cirrhosis |
3.9% |
| Melanocytic Naevus |
3.9% |
| Osteopenia |
3.9% |
| Overdose |
3.9% |
| Pancreatitis Acute |
3.9% |
| Pneumonia |
3.9% |
| Swollen Tongue |
3.9% |
| Thrombocytopenia |
3.9% |
| Tremor |
3.9% |
| Upper-airway Cough Syndrome |
3.9% |
| Vomiting |
3.9% |
| Weight Decreased |
3.9% |
|
| Interacting |
| Product Used For Unknown Indication |
27.3% |
| Hepatitis C |
13.6% |
| Erectile Dysfunction |
9.1% |
| Major Depression |
9.1% |
| Pain |
9.1% |
| Affective Disorder |
4.5% |
| Cough |
4.5% |
| Diarrhoea |
4.5% |
| Hypogonadism |
4.5% |
| Muscle Spasms |
4.5% |
| Nausea |
4.5% |
| Vomiting |
4.5% |
|
| Dizziness |
33.3% |
| Drug Interaction |
33.3% |
| Priapism |
33.3% |
|
